PTLA
VOYA Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-38,789
| Closed | -$277K | – | 2703 |
|
|
2020
Q1 | $277K | Buy |
38,789
+1,651
| +4% | +$11.8K | ﹤0.01% | 1960 |
|
|
2019
Q4 | $887K | Buy |
37,138
+8,584
| +30% | +$205K | ﹤0.01% | 1523 |
|
|
2019
Q3 | $766K | Buy |
28,554
+2,209
| +8% | +$59.3K | ﹤0.01% | 1491 |
|
|
2019
Q2 | $715K | Sell |
26,345
-60
| -0.2% | -$1.63K | ﹤0.01% | 1552 |
|
|
2019
Q1 | $916K | Sell |
26,405
-407
| -2% | -$14.1K | ﹤0.01% | 1405 |
|
|
2018
Q4 | $523K | Sell |
26,812
-523,966
| -95% | -$10.2M | ﹤0.01% | 1692 |
|
|
2018
Q3 | $14.7M | Buy |
550,778
+68,228
| +14% | +$1.82M | 0.03% | 509 |
|
|
2018
Q2 | $18.2M | Buy |
482,550
+219,575
| +83% | +$8.29M | 0.04% | 462 |
|
|
2018
Q1 | $8.59M | Sell |
262,975
-88,738
| -25% | -$2.9M | 0.02% | 645 |
|
|
2017
Q4 | $17.1M | Buy |
351,713
+73,269
| +26% | +$3.57M | 0.04% | 460 |
|
|
2017
Q3 | $15M | Buy |
278,444
+53,059
| +24% | +$2.87M | 0.03% | 472 |
|
|
2017
Q2 | $12.7M | Sell |
225,385
-161,305
| -42% | -$9.06M | 0.03% | 532 |
|
|
2017
Q1 | $15.2M | Sell |
386,690
-34,869
| -8% | -$1.37M | 0.03% | 473 |
|
|
2016
Q4 | $9.46M | Sell |
421,559
-42,947
| -9% | -$964K | 0.02% | 598 |
|
|
2016
Q3 | $10.5K | Buy |
464,506
+49,900
| +12% | +$1.13K | 0.02% | 563 |
|
|
2016
Q2 | $9.79M | Buy |
414,606
+58,130
| +16% | +$1.37M | 0.02% | 576 |
|
|
2016
Q1 | $7.27M | Buy |
356,476
+74,350
| +26% | +$1.52M | 0.02% | 644 |
|
|
2015
Q4 | $14.5M | Buy |
282,126
+1,325
| +0.5% | +$68.2K | 0.04% | 439 |
|
|
2015
Q3 | $12M | Buy |
280,801
+259,652
| +1,228% | +$11.1M | 0.03% | 497 |
|
|
2015
Q2 | $963K | Buy |
21,149
+1,052
| +5% | +$47.9K | ﹤0.01% | 1462 |
|
|
2015
Q1 | $763K | Hold |
20,097
| – | – | ﹤0.01% | 1630 |
|
|
2014
Q4 | $569K | Hold |
20,097
| – | – | ﹤0.01% | 1850 |
|
|
2014
Q3 | $508K | Hold |
20,097
| – | – | ﹤0.01% | 1897 |
|
|
2014
Q2 | $586K | Buy |
+20,097
| New | +$586K | ﹤0.01% | 1862 |
|